ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $2,310,000 | -29.7% | 57,140 | 0.0% | 0.02% | -27.6% |
Q2 2015 | $3,288,000 | -9.6% | 57,140 | 0.0% | 0.03% | -3.3% |
Q1 2015 | $3,638,000 | -38.8% | 57,140 | -40.7% | 0.03% | -50.8% |
Q4 2014 | $5,946,000 | +59.0% | 96,303 | 0.0% | 0.06% | +29.8% |
Q3 2014 | $3,739,000 | +12.7% | 96,303 | 0.0% | 0.05% | +14.6% |
Q2 2014 | $3,318,000 | -20.3% | 96,303 | 0.0% | 0.04% | -22.6% |
Q1 2014 | $4,161,000 | -57.7% | 96,303 | -61.0% | 0.05% | -61.9% |
Q4 2013 | $9,842,000 | +6.1% | 247,036 | 0.0% | 0.14% | +5.3% |
Q3 2013 | $9,274,000 | +39.7% | 247,036 | 0.0% | 0.13% | +0.8% |
Q2 2013 | $6,638,000 | – | 247,036 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 5,976,526 | $368,991,000 | 11.95% |
HWG Holdings LP | 155,584 | $9,606,000 | 6.84% |
DOWLING & YAHNKE LLC | 676,313 | $41,756,000 | 5.20% |
Ghost Tree Capital, LLC | 150,000 | $9,261,000 | 4.44% |
WILLIAM HARRIS INVESTORS INC | 276,870 | $17,094,000 | 4.41% |
GRAYBILL WEALTH MANAGEMENT, LTD. | 61,225 | $3,780,000 | 2.87% |
Opus Point Partners Management, LLC | 45,418 | $2,804,000 | 2.77% |
PINNACLE ASSOCIATES LTD | 1,917,838 | $118,407,000 | 2.32% |
Ghost Tree Capital, LLC | 50,000 | $3,087,000 | 1.48% |
Adamant Biomedical Investments AG | 100,000 | $6,174,000 | 1.48% |